The Burst
Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment, » Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read MoreThe Ivy
3 Dividend Stocks Worth Pouncing On?
If you’re looking for steady income, dividend stocks are a powerful tool providing regular cash payouts as you wait for stock price appreciation.
While no dividend are paid out at the behest of the Board of Directors and so never guaranteed, four top dividend stocks to consider this year include Genuine Parts Company (GPC),
» Read more about: 3 Dividend Stocks Worth Pouncing On? »
Read MoreThe Daily
Dragging Your Feet on Saving for Retirement? Here's How to Jump In
Imagine waking up one day and realizing you’ve procrastinated so long that a comfortable retirement seems completely out of reach. Especially when the ‘magic number’ to retire comfortably is more than you think — nearly $1.5 million. The biggest problem with delaying retirement planning is that it can be extremely hard to make up for lost time.
» Read more about: Dragging Your Feet on Saving for Retirement? Here's How to Jump In »